International cooperation against the world drug problem A/RES/69/201 working towards the goal of universal access to comprehensive prevention programmes and treatment, care and related support services, in full compliance with the international drug control conventions and in accordance with national legislation, taking into account all relevant General Assembly resolutions and, when applicable, the revised technical guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users, issued by the World Health Organization, the United Nations Office on Drugs and Crime and the Joint United Nations Programme on HIV/AIDS, and requests the Office to carry out its mandate in this area in close cooperation with relevant organizations and programmes of the United Nations system, such as the World Health Organization, the United Nations Development Programme and the Joint United Nations Programme on HIV/AIDS; 13. Urges Member States, where appropriate, to develop national responses to address the issue of drug-affected driving by, inter alia, exchanging information and best practices on effective responses, including through engagement with the international scientific and legal communities; 14. Notes with concern that the availability of internationally controlled drugs for medical and scientific purposes, particularly for the relief of pain and for palliative care, remains low to non-existent in many countries of the world, and highlights the need for Member States, the Commission on Narcotic Drugs and the International Narcotics Control Board, in cooperation with the United Nations Office on Drugs and Crime and the World Health Organization, as appropriate, to address that situation by promoting measures to ensure their availability and accessibility for medical and scientific purposes, in accordance with national legislation, while simultaneously preventing their diversion, abuse and trafficking, in order to realize the aims of the three international drug control conventions and other relevant international instruments; 15. Urges all Member States to enact comprehensive measures aimed at stemming the abuse of prescription drugs, in particular through the establishment of awareness-raising initiatives targeting the general public and health-care providers; 16. Acknowledges the continuing efforts made and the progress achieved in countering the world drug problem, notes with great concern the continuing illicit production of and trafficking in opiates, the continuing illicit manufacture of and trafficking in cocaine, the increasing illicit production of and trafficking in cannabis, the ongoing global spread of the illicit manufacture of amphetamine-type stimulants and the increasing diversion of precursors, as well as the related distribution and use of illicit drugs, and stresses the need to strengthen and intensify joint efforts at the national, regional and international levels to tackle those global challenges in a more comprehensive manner, in accordance with the principle of common and shared responsibility, including by means of enhanced and bettercoordinated technical and financial assistance; 17. Expresses its concern that, despite all the efforts of Member States and the international community, and according to the World Drug Report 2014 of the United Nations Office on Drugs and Crime, overall the global situation with regard to the prevalence of illicit drug use and problem drug use is generally stable, with the total global number of drug users increasingly commensurate with the growth of the world population; 18. Stresses that it is absolutely imperative for Member States to strengthen international efforts in order to achieve more effective results in countering the world drug problem; 7/14